Smither John W Insider Trades

Insider Trading History

Track insider trading activity for Smither John W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $491k 15,300 shares
Last Trade
Jan 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$663k 18,700 shares
$35.45
$32.11
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $317k 15,300 shares
Last Trade
Jan 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$432k 18,700 shares
$23.10
$20.70
Genelux
Genelux GNLX
Director
Holding Value $225k 74,994 shares
Last Trade
Aug 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 28,576 shares
$3.64
$3.00
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $144k 6,960 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 6,960 shares
$14.78
$20.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $223k 6,960 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 6,960 shares
$26.04
$32.11
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $673k 32,500 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$481k 32,500 shares
$14.80
$20.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $1.04M 32,500 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$840k 32,500 shares
$25.85
$32.11
Genelux
Genelux GNLX
Director
Holding Value $158k 52,711 shares
Last Trade
Aug 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.9k 50,469 shares
$1.96
$3.00
Genelux
Genelux GNLX
Director
Holding Value $151k 50,469 shares
Last Trade
Aug 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.9k 50,469 shares
$1.96
$3.00
Genelux
Genelux GNLX
Director
Holding Value $39.5k 13,170 shares
Last Trade
May 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$35k 12,500 shares
$2.80
$3.00
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Feb 13, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$235k 34,097 shares
$6.90
$21.35
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Chief Financial Officer
Holding Value $243k 11,365 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.4k 11,365 shares
$6.90
$21.35
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $207k 10,000 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.9k 10,000 shares
$0.89
$20.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $321k 10,000 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 10,000 shares
$11.17
$32.11
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $0 0 shares
Last Trade
Dec 29, 2023 Sale
$190k 18,600 shares
$10.22
$32.11
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $0 0 shares
Last Trade
Dec 29, 2023 Sale
$16.6k 18,600 shares
$0.89
$20.70
Applied Molecular Transport
Applied Molecular Transport AMTI
Director
Holding Value $0 0 shares
Last Trade
Dec 27, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21k 80,000 shares
$0.26
$0.26
Genelux
Genelux GNLX
Director
Holding Value $20.8k 6,920 shares
Last Trade
Sep 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.7k 900 shares
$20.78
$3.00
Genelux
Genelux GNLX
Director
Holding Value $25.3k 8,447 shares
Last Trade
Sep 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$189k 8,447 shares
$22.40
$3.00
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Chief Financial Officer
Holding Value $2.67M 125,000 shares
Last Trade
Aug 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.07M 125,000 shares
$8.54
$21.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up